This page lists all pharmaceutical reports related to the field of Neurodegenerative & Neuroelectrophysiological Disorders. The reports include market research reports and pipeline analyses.
Displaying 101 - 150 of 162 results
- Alzheimers Disease Biomarkers, 2009
- Epilepsy - Future market upgrade following new drug launches
- Pharmaceutical Company Outlook to 2013
- Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape
- UpdatesPlus Nicotinic Receptors - Current Research and Development - February 2009
- Point of Care Testing - Special Conference
- UpdatesPlus Nicotinic Receptors - Current Research and Development - March 2009
- The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- The Global Multiple Sclerosis Market 2009-2024
- Stem Cells - World Analysis 2009-2024
- Companion Biomarkers in Drug Development
- Alzheimer's Disease: Markets, Pipeline and Opportunities 2009
- Therapeutic Monoclonal Antibodies Markets
- Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
- Vaccine antigen delivery technologies - Molecular systems to open new markets
- New Approaches to Pharma Research and Development: Evolving strategies to rejuvenate Research and Development efficiency
- Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
- UpdatesPlus Nicotinic Receptors - Current Research and Development - June 2009
- Key Trends In Drug-diagnostic Co-development: Identifying collaborative opportunities and navigating regulatory challenges
- Accelerating Lead Generation: Emerging technologies and strategies
- Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
- UpdatesPlus Nicotinic Receptors - Current Research and Development - July 2009
- UpdatesPlus Nicotinic Receptors - Current Research and Development - September 2009
- Stroke: Competitive Treatments and Market Entry Considerations, 2010
- Monoclonal Antibody Therapeutics 2009-2024
- World Generics Market 2009-2024
- World Neurodegenerative Diseases Market 2009-2024
- Amyotrophic Lateral Sclerosis - Therapy Area Pipeline Report
- World Neurodegenerative Diseases Market 2009-2024
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- Global Pharmaceutical Biotech Market 2010-2025
- Pipeline Insight: Multiple Sclerosis - Risk-benefit ratio under the spotlight for potent pipeline drugs
- Therapeutic Vaccines - A far-off promise of greatness
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- Alzheimer's Disease: Current Treatment Practices and Opportunities, 2010
- Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
- Pipeline Insight: Alzheimer's Disease - The ultimate high-risk, high-reward therapy market
- Pipeline Insight: Mild Cognitive Impairment - Unlocking the potential of prodromal Alzheimer's disease and beyond
- Stakeholder Opinions: Spinal Cord Injury - Attractive niche market with multi-billion dollar potential
- Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016
- The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
- Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- The Future of the Neurology Devices Market to 2016 – Market Forecasts, Competitive Landscape and Pipeline Analysis